![](/img/cover-not-exists.png)
DOP002 Vedolizumab treatment persistence up to 3 years: post hoc analysis in vedolizumab-naïve patients from the GEMINI LTS study
Vermeire, S, Loftus Jr, E V, Khalid, J M, Tudor, D, Akbari, M, Demuth, D, Peyrin-Biroulet, LVolume:
12
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx180.039
Date:
January, 2018
File:
PDF, 1.07 MB
english, 2018